ArticleCardio-oncology (London, England)2026
Impact of echocardiographic hemodynamics on outcomes among patients with polycythemia vera or essential thrombocythemia.
Article in Cardio-oncology (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPulmonary hypertension (PH) and high-output heart failure (HOHF) are associated with myeloproliferative neoplasms (MPNs), including essential thrombocythemia (ET) and polycythemia vera (PV). Transthoracic echocardiography (TTE) is a non-invasive modality that can be used for the screening of PH and HOHF. However, the impact of echocardiographic HOHF on TTE on outcomes of patients with ET or PV is unclear.
methodsThis was a multicenter, retrospective cohort study of patients with ET or PV with ≥ 1 TTE. Estimated pulmonary artery systolic pressure (PASP) and cardiac index were calculated using doppler TTE. Patients were categorized based on TTE hemodynamics as echocardiographic HOHF (PASP > 40 mmHg and cardiac index > 3.54 L/min/m2), elevated PASP alone, elevated cardiac index alone, and normal PASP and cardiac index. Primary outcome was all-caused death or MPN disease progression.
resultsA total of 272 patients (150 PV, 122 ET) were included, 16 (5.9%) with echocardiographic HOHF, 31 (11.4%) elevated cardiac index alone, 63 (23.2%) elevated PASP alone, and 147 (54.0%) with normal hemodynamics. After multivariable Cox proportional hazards regression, echocardiographic HOHF (adjusted HR 3.35, 95% CI 1.53-7.34) and elevated PASP alone (adjusted HR 2.89, 95% CI 1.70-4.92) were associated with increased of primary outcome. Increased risk of HF hospitalizations was seen across all abnormal hemodynamic vs. normal hemodynamics.
conclusionsAmong patients with ET or PV, echocardiographic HOHF and elevated PASP alone were associated with increased risk of death or MPN disease progression. Prospective studies are needed to identify patients at risk of HOHF and PH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.